Clinical research and application of therapeutic drug monitoring technology in new and recurrent infectious diseases

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000035629

Enrollment

Unknown

Registered

2020-08-15

Start date

2020-10-01

Completion date

Unknown

Last updated

2020-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

New and recurrent infectious diseases

Interventions

TDM:NA

PPK:NA

Drug-drug interaction:NA

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. The informed consent was signed before the trial, and the content, process and possible adverse reactions were fully understood; 2. Adult medication: subjects aged 18 years (including 18 years) and above, both male and female; children and adolescents: under 18 years old, both male and female; 3. Patients with new and recurrent infectious diseases admitted to Shanghai public health clinical center; 4. Take new and recurrent infectious disease drugs, with accurate medication time, medication name and blood collection time.

Exclusion criteria

Exclusion criteria: 1. The researcher judged the unsuitable subjects; 2. Incomplete record of medication information.

Design outcomes

Primary

Measure	Time frame
Drug concentration;	—

Countries

China

Contacts

Public ContactLijun Zhang

Shanghai Public Health Clinical Center

zhanglijun1221@163.com+86 18916015028

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026